Navigation Links
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
Date:8/14/2009

outlets, to receiving three new product approvals which further diversifies our portfolio, we have set the foundation for long-term growth and profitability in our business. We remain focused on introducing higher margin products and building brand value which will enable us to achieve further market share gains," concluded Mr. Wang.

Conference Call

The Company will host a conference call to discuss the 2009 second quarter financial results on Friday, August 14, 2009 at 10:30 a.m. EDT. Interested participants should call 877-941-1848 within the United States, or US +1-480-629-9722 if calling internationally. The conference ID is 4139784. It is advisable to dial in approximately 5-10 minutes prior to 10:30 a.m. EDT. This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website athttp://www.viavid.netor at the following link: http://viavid.net/dce.aspx?sid=00006906 .

About Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly-owned subsidiary in China, develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based OTC products, two prescription-based pharmaceuticals and thirteen nutrients. The Company has adopted international standards and is in the process of applying for three patents.

Safe Harbor

Certain statements in this release concerning our future growth prospects are forward-looking st
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
2. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
3. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
4. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
5. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
8. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
9. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
10. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
11. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... HARBIN, China, Dec. 15 /PRNewswire-Asia-FirstCall/ -- China Sky ... Company") (Nasdaq: CSKI ), a,leading fully integrated ... People,s Republic of China ("PRC"), today,announced that the ... in the 2009,Edition of the National Basic Medical ... , The 30 medicines ...
(Date:12/15/2009)... for Atomic Force Microscopy (AFM) have been developed and ... at the liquid/air interface. The NeedleProbes’ cylindrical geometry enables ... rate and viscosity - all in a single force distance ... ... 2009 -- New, constant diameter NeedleProbes are enabling ...
(Date:12/15/2009)... -- On January 20th, 2010, the inaugural European ... Professionals (ISMPP) will be held at the Royal ... 100 attendees are expected at this prestigious event, ... publishers, medical writers and medical agencies to discuss ... impact of guidelines and regulations such as GPP-2, ...
(Date:12/14/2009)... OAKS, Calif., Dec. 14 Array BioPharma ... AMGN ) today announced that they entered ... to Array,s small-molecule glucokinase activator program, including ARRY-403, ... trial in patients with Type 2 diabetes. ... Array will receive an upfront payment of $60 ...
Breaking Biology Technology:China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7
... On October 11, 2005, the Centers for Medicare ... Human Services Office of Inspector General ("OIG") published ... effort to advance the goal of widespread adoption ... and other health care providers. These proposed rules ...
... Healthcare's LightSpeed VCT, the world's first volume ... the Wall Street Journal in the ... Innovation Awards. The annual awards recognize technological breakthroughs ... in a wide range of areas, including medicine. ...
... a significant presence in the bicycle industry by buying ... market. But the Madison, Wis.-based company has jumped full ... frequency identification (RFID) technology into its systems. , ,The ... and Roadmaster along with newer names such as GT ...
Other Biology Technology:The use of e-prescribing and electronic health records is accelerating 2The use of e-prescribing and electronic health records is accelerating 3The use of e-prescribing and electronic health records is accelerating 4The use of e-prescribing and electronic health records is accelerating 5Pacific Cycle rides full speed into RFID 2Pacific Cycle rides full speed into RFID 3
(Date:12/16/2009)... iQor, a global provider of business process ... InfoWorld 100 Awards Top 100 IT project of ... the first submission for iQor. ,, "We are honored ... said Vikas Kapoor, president and CEO of iQor. "TeQ21 ... us to work faster, smarter and with the added ...
(Date:12/16/2009)... HARBOR, Fla., Dec. 2 Communication ... a leading supplier of electronic signature solutions ... industry* and the recognized leader** in biometric ... a leading International Electronic Document Management (EDM) ... entered an agreement to provide their products ...
(Date:12/16/2009)... Texas, Dec. 8, 2009 National ... in industrial measurement and control, and DENSO ... automation using robotics technology, today announced their ... technology with DENSO robotic arms. The collaboration ... research and flexible manufacturing applications. In today,s ...
Breaking Biology News(10 mins):iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5Garner to Lead Virginia Bioinformatics Institute 14513 1Garner to Lead Virginia Bioinformatics Institute 14513 2Garner to Lead Virginia Bioinformatics Institute 14513 3MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference 26amp 3B Exhibition 5539 1MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference 26amp 3B Exhibition 5539 2MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference 26amp 3B Exhibition 5539 3MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference 26amp 3B Exhibition 5539 4ESC press statement 3A Cigarettes on sale on the internet 59661 1ESC press statement 3A Cigarettes on sale on the internet 59661 2ESC press statement 3A Cigarettes on sale on the internet 59661 3
... in French . , A study appearing ... demonstrates that a synthetic new chemical entity protects against ... enhances exercise endurance by enhancing fat utilization in certain ... developed by Sirtris, a a GSK company, and the ...
... Imagine descending in a submarine to the ice-cold, ink-black ... of the Atlantic. Here the tops of the hills ... studied the formation of these unknown cold-water relatives of ... the development of carbonate mounds dominated by cold-water corals ...
... themselves or as an ingredient in a variety of foods, ... spot in the hearts and stomachs of U.S. consumers. ... of fresh peppers at an all-time high, only a fraction ... 70 percent of all fresh peppers consumed in the U.S. ...
Other Biology News:A new weapon in the fight against obesity and diabetes 2Coral reefs found growing in cold, deep ocean 2New hybrid plants could prompt more prodigious pepper production in Southwest 2New hybrid plants could prompt more prodigious pepper production in Southwest 3New hybrid plants could prompt more prodigious pepper production in Southwest 4
... induced prior to DNA purification increasing DNA ... single-copy BACs with the high yields associated ... kits provide the linearized vector and associated ... necessary to create a 10X human BAC ...
...
... cultured in DMEM with 4 mM L-glutamine and ... In order to keep the antigens in their ... The cells are arrayed on a 12-well (5 ... specifically treated to enhance cellular attachment and to ...
... Systems provide rapid, precise localization of ... frozen or paraffin-embedded tissue, cytospins and ... facilitate double or triple labeleing experiments, ... with primary antibodies of different animal ...
Biology Products: